M
Massimo F. Piepoli
Researcher at University of Parma
Publications - 103
Citations - 19155
Massimo F. Piepoli is an academic researcher from University of Parma. The author has contributed to research in topics: Heart failure & Heart rate variability. The author has an hindex of 55, co-authored 103 publications receiving 16699 citations. Previous affiliations of Massimo F. Piepoli include National Institutes of Health & Academy for Urban School Leadership.
Papers
More filters
Journal ArticleDOI
Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
William Wijns,Philippe Kolh,Nicolas Danchin,Volkmar Falk,Stefan James,Miodrag Ostojic,Massimo F. Piepoli,Charles Pirlet,José L. Pomar,Flavio Ribichini,Martin J. Schalij,Paul Sergeant,Patrick W. Serruys,Sigmund Silber,David P. Taggart +14 more
TL;DR: Guidelines and Expert Consensus Documents summarize and evaluate all available evidence to assist physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome and the risk–benefit ratio of diagnostic or therapeutic means.
Journal ArticleDOI
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
José Luis Zamorano,Patrizio Lancellotti,Daniel Rodriguez Muñoz,Victor Aboyans,Riccardo Asteggiano,Maurizio Galderisi,Gilbert Habib,Daniel J. Lenihan,Gregory Y.H. Lip,Alexander R. Lyon,Teresa López Fernández,Dania Mohty,Massimo F. Piepoli,Juan Tamargo,Adam Torbicki,Thomas M. Suter +15 more
TL;DR: This document describes the development and use of angiotensin-converting enzyme, a non-volatile substance that acts as a “spatially aggregating substance” to reduce the chances of heart attack in women.
Journal ArticleDOI
Guidelines on myocardial revascularization.
Philippe Kolh,William Wijns,Nicolas Danchin,Carlo Di Mario,Volkmar Falk,Thierry Folliguet,Scot Garg,Kurt Huber,Stefan James,Juhani Knuuti,Jose Lopez-Sendon,Jean Marco,Lorenzo Menicanti,Miodrag Ostojic,Massimo F. Piepoli,Charles Pirlet,José L. Pomar,Nicolaus Reifart,Flavio Ribichini,Martin J. Schalij,Paul Sergeant,Patrick W. Serruys,Sigmund Silber,Miguel Sousa Uva,David P. Taggart +24 more
TL;DR: Guidelines and Expert Consensus Documents summarize and evaluate all available evidence with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome and the risk benefit ratio of diagnostic or therapeutic means.
Journal ArticleDOI
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
José Luis Zamorano,Patrizio Lancellotti,Daniel Rodriguez Muñoz,Victor Aboyans,Riccardo Asteggiano,Maurizio Galderisi,Gilbert Habib,Daniel J. Lenihan,Gregory Y.H. Lip,Alexander R. Lyon,Teresa López Fernández,Dania Mohty,Massimo F. Piepoli,Juan Tamargo,Adam Torbicki,Thomas M. Suter,Stephan Achenbach,Stefan Agewall,Lina Badimon,Gonzalo Barón-Esquivias,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Scipione Carerj,Veronica Dean,Çetin Erol,Donna Fitzsimons,Oliver Gaemperli,Paulus Kirchhof,Philippe Kolh,Petros Nihoyannopoulos,Piotr Ponikowski,Marco Roffi,Antonio Vaz Carneiro,Stephan Windecker +34 more
TL;DR: No abstract available Keywords: European Society of Cardiology; arrhythmias; cancer therapy; cardio-oncology; cardiotoxicity; chemotherapy; early detection; ischaemia; myocardial dysfunction; surveillance.
Journal ArticleDOI
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).
TL;DR: Meta-analysis of randomised trials to date gives no evidence that properly supervised medical training programmes for patients with heart failure might be dangerous, and indeed there is clear evidence of an overall reduction in mortality.